V8 Peptides — Engineered Performance
Research Library
Research Peptide Stacks: How to Read a Blend Label
Research CompoundsQuality & Testing

Research Peptide Stacks: How to Read a Blend Label

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

How do you read the label on a research peptide stack? Look for three things: how the size is written, which components are named, and what is not stated. "5 mg / 5 mg" means two components at 5 mg each (10 mg in total); "70 mg total (50 / 10 / 10)" means three components whose masses add up to 70 mg; "80 mg blend" gives only a total, so the split has to come from the product description or the certificate. From the stated masses, each component's concentration after reconstitution is its own mass divided by the diluent volume. Equal masses are not equal molecule counts, so convert to moles with each molecular weight before comparing stacks.

Rankings of stacks are easy to find and hard to use. A more durable skill is reading what a stack actually contains and working out what a given vial can support. This article decodes the size notations used on the V8 blend product pages, shows how to do the per-component arithmetic with formulas alone, and lists the questions worth asking of any blend. For laboratory research use only; not for human consumption.

Size notation on current V8 blend pages

ProductSize as writtenWhat it tells youWhat it does not tell you
BPC-157 + TB-500 (Wolverine)10 mg / 10 mg (20 mg total)Two components at equal massEqual moles (they are not)
CJC-1295 (no DAC) + ipamorelin5 mg / 5 mg; 10 mg / 10 mgTwo components at equal mass, two vial sizesMolar ratio
Tesamorelin + ipamorelin5 mg / 5 mg; 12 mg / 3 mgEqual-mass and 4:1 mass variantsWhich number belongs to which component, unless the page states the order
GHK-Cu + KPV60 mg of blended material in totalTotal mass onlySplit between components
Glow stack70 mg total (50 / 10 / 10)Three components, split givenOrder of the three numbers unless stated
KLOW stack80 mg blendFour named components, total massThe split
NAD+ + MOTS-c400 mg / 20 mgListed as coming soon, not yet on saleAvailability date

The pattern is that the more components a stack has, the less the label reveals by itself. When a page gives only a total, the split must come from the product description and the lot document, and if neither states it the analytical answer has to come from your own chromatography. See peptide blends and research stacks for the general case.

The arithmetic, as formulas only

Four relationships answer nearly every label question. None needs a table.

  1. Component mass = stated mass for that component (for a "total" label with a stated split, the split value).
  2. Component concentration = component mass ÷ diluent volume.
  3. Moles of a component = component mass ÷ its molecular weight.
  4. Molar ratio between two components = moles of A ÷ moles of B.

The fourth is the one most often skipped, and the most informative. A mass ratio of 1:1 between a small peptide of around one kilodalton and one of around four kilodaltons is roughly a 4:1 molar ratio. When a protocol, a paper or a product description gives a ratio, check whether it is by mass or by moles before using it. The reconstitution calculator performs the concentration conversions, and the calculator guide explains each field. Molecular weights for individual compounds are on their own product pages, for example tesamorelin and ipamorelin.

Questions to ask of any blend

QuestionWhy it mattersWhere to look
Are all components named, with masses?Unnamed or undefined components cannot be controlled forProduct page, lot document
Is the split stated, or only the total?Per-component concentration depends on itProduct page; ask or measure if absent
Is the purity statement per component or for the blend?A blend-level percentage can hide a poorly pure componentLot document; how to read a COA
Are the components chemically compatible?Copper, thiols and oxidation-prone residues can interactCopper and blends
Is there a lot document?Ties vial to analytical dataCOA library
Can single-agent controls be obtained?Needed to interpret any combinationCatalog

The generic quality framework for synthetic peptides, including identity, purity, content and impurity profile, is described by Vergote and colleagues (2009); a blend multiplies each of those questions by the number of components. Why a "≥98%" figure is the start of the analysis and not its conclusion is explained in understanding HPLC purity.

Worked reading of three labels

Take a label that reads "5 mg / 5 mg" for two peptides, A and B. The component masses are both 5 mg. If A has a molecular weight near 1 kDa and B near 4 kDa, A is present at about four times the molar amount of B: 5 mg ÷ 1000 g/mol is about 5 micromoles, and 5 mg ÷ 4000 g/mol is about 1.25 micromoles. After reconstitution in a given volume, the mass concentration of each component is the same, but the molar concentrations are not. An experiment designed around a 1:1 molar ratio would need a different mass ratio, which a fixed-ratio blend cannot supply.

Now a label that reads "12 mg / 3 mg". The masses are 12 mg and 3 mg, a 4:1 mass ratio. The molar ratio depends again on the two molecular weights, and could be near 1:1 if the larger-mass component is also the lighter molecule, or very different if it is the heavier one. The only way to know is to divide by the molecular weights, which are on the individual product pages or in the lot document.

Finally a label that reads "80 mg blend" with four named components. Here neither the split nor the molar ratio can be read. The reasonable options are to find the split in the product description or lot document, to measure it, or to use the blend only for experiments in which the exact ratio is not the point, such as a pathway screen that is later followed up with single compounds.

Common label-reading errors

  • Assuming the first number belongs to the first component without checking the page; confirm the order.
  • Reading the total as the mass of each component. A 20 mg total with two components is not 20 mg of each.
  • Comparing stacks by total mass. A larger total only means more material, not more of any one component.
  • Quoting a ratio without saying whether it is by mass or by moles. Always state the basis.
  • Ignoring salt and water content. Net peptide content is lower than the gross mass of powder, so per-component amounts are approximate unless the lot document reports content.

Compatibility and stability within a blend

A blend is a shared solution once reconstituted, and the stability of every component is affected by the others. Manning and colleagues (2010) review the chemical and physical degradation routes for peptides and proteins, including oxidation, deamidation, aggregation and adsorption. In a mixture, an oxidant or a metal ion present for one component can act on another. Co-lyophilization, where the components are dried together in one vial, helps by fixing the ratio and keeping everything dry until use, but it does not prevent reactions once the powder is dissolved. In practice, a laboratory working with a blend should reconstitute one vial, run HPLC at time zero and at planned intervals, and compare the peak areas with the same material kept frozen. Handling for blends is explained in BPC-157 and TB-500 blend reconstitution and CJC-1295 and ipamorelin reconstitution and storage.

Single compounds versus stacks

The case for a stack is control of ratio and fewer handling steps. The case against is that a blend commits you to one ratio and one solvent for all components. The decision rule is simple: if the question is about a fixed combination at a fixed ratio, a pre-blended vial is efficient; if the question is about ratio or about one component's contribution, use single compounds. A rigorous combination study needs single-agent arms either way, and the combination-analysis methods are set out by Chou (2006) and compared by Foucquier and Guedj (2015). For a catalog-level comparison of three of the multi-component products, see Glow versus KLOW versus Wolverine.

Handling common to all stacks

Each blend page lists a lyophilized powder, refrigeration at 2–8 °C, −20 °C for long-term storage and protection from heat, moisture and light. Allow a sealed vial to reach room temperature before opening, add the diluent down the vial wall, swirl rather than shake and record the lot, date, diluent and calculated concentration. Reconstituted stock should be divided into single-use portions where freezing is planned, because repeated freeze-thaw cycles degrade peptides. Details are in how to reconstitute a lyophilized peptide and storing research peptides.

Frequently asked questions

What does '5 mg / 5 mg' mean on a blend label?

It lists two components with 5 mg of each, for 10 mg of material in total. The order of the two numbers corresponds to the order in which components are named, so check the product page.

What does 'total' mean in '70 mg total (50 / 10 / 10)'?

The three component masses add up to 70 mg. The split is given in the parentheses in the order the components are named.

What if only a total is given?

Then the per-component masses cannot be read from the label. They have to come from the product description or lot document, or be measured analytically before per-component concentrations are used.

How is component concentration found after reconstitution?

Divide the component's mass by the diluent volume. The reconstitution calculator on the site performs the unit conversion.

Why convert to moles when comparing stacks?

Components differ in molecular weight, so equal masses contain different numbers of molecules. A molar ratio describes the actual stoichiometry.

Does a blend need single-compound controls?

Yes, for any study that interprets the combination. Single-agent arms are the reference against which synergy or antagonism is judged.

Can the components of a blend degrade each other?

They can. Oxidation, metal ions and pH can affect multiple components, so stability in the mixture should be confirmed by HPLC over the intended storage period.

Is NAD+ with MOTS-c available?

The site lists it as a 400 mg / 20 mg blend that is coming soon and not yet on sale. The single-compound pages are available.

How are blends stored?

The product pages state refrigeration at 2–8 °C, −20 °C for long-term storage and protection from heat, moisture and light.

Related reading: Research Peptide Supplier Checklist: 10 Things to Verify, How to Choose Research Peptides in 2026: By Question, Peptides in Aging Research: A 2026 Evidence Review.

References

  1. Vergote V, Burvenich C, Van de Wiele C, De Spiegeleer B. Quality specifications for peptide drugs: a regulatory-pharmaceutical approach. J Pept Sci. 2009;15(11):697-710. doi:10.1002/psc.1167
  2. Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. doi:10.1007/s11095-009-0045-6
  3. Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006;58(3):621-681. doi:10.1124/pr.58.3.10
  4. Foucquier J, Guedj M. Analysis of drug combinations: current methodological landscape. Pharmacol Res Perspect. 2015;3(3):e00149. doi:10.1002/prp2.149
  5. Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021;20(4):309-325. doi:10.1038/s41573-020-00135-8
  6. Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7:48. doi:10.1038/s41392-022-00904-4

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.